Activate Now
ProHealth me-cfs Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Misdiagnosis on a grand scale?

Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease

Repair Damaged Mitochondria and Reduce Fatigue Up to 45%

Are All the "Feel-Good" Pathways Blocked in Fibromyalgia and Chronic Fatigue Syndrome?

Chronic Fatigue Syndrome, Fibromyalgia and Mitchondrial Disorders: A Comparison Plus the MitoQ Trial...

5 Things I've Learned About Chronic Illness Through Mindfulness

An assessment of fatigue in patients with postural orthostatic tachycardia syndrome

Increased Vulnerability to Pattern-Related Visual Stress in Myalgic Encephalomyelitis

Maintenance of Chronic Fatigue Syndrome (CFS) in Young CFS Patients Is Associated with the 5-HTTLPR ...

NIH takes action to bolster research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Print Page
Email Article

For Those Wondering About Progress on Rituximab Trials for Chronic Fatigue Syndrome

  [ 26 votes ]   [ Discuss This Article ] • March 29, 2012

[Note: the following statement was translated from the Norwegian on Mar 16 by Ellen V. Piro and Eva Stormorken, Norwegian ME Association. The translation has been approved by Professor Olav Mella, is published with his permission, and has been shared broadly via Invest in ME and Co-Cure Listserv. We know that: researchers collaborating with the Cedars-Sinai Chronic Fatigue Syndrome Research Center have planned to take part in Rituximab research, and Dr. Kogelnik’s new Open Medicine Institute is running a pilot rituximab trial via its ME/CFS physician research network.]


What is Happening with the Research into ME and Rituximab?

By Anette Gilje, Secretary General, Norwegian ME Association

The cancer doctors Oystein Fluge and Olav Mella, Haukeland University Hospital, published their study on ME and rituximab last autumn.

Following their sensational and promising findings that some people with ME had benefited from the immune modulator rituximab, the Government allocated two million Norwegian Kroners (approx. 220,000 pounds or $351,370) to the Western Norway Regional Health Authority to help fund a larger follow-up study.

• This is far from enough to fund a larger, double-blinded multi-center study which is necessary to determine the scientific research question: 'Does rituximab have an effect on this patient group, or not?' says Professor Mella.

• We do believe it has, but this has to be confirmed in a larger study to gain scientific credibility internationally.

• To be reasonably certain to answer the question, the study probably has to include between 120 and 140 carefully selected patients that meet the Canadian Consensus criteria.

The patient-sample will be divided into two groups, one of which will receive active treatment with rituximab, the other placebo (i.e., inactive substance). Both groups will be closely observed for potential effects and adverse reactions.

Providing the study can confirm a significant effect in the group that was given rituximab and the adverse reactions are acceptable, the placebo group will be offered treatment with rituximab at a later point of time.

A scientific study of this scale cannot be initiated before the whole project is fully funded.

So far Drs. Fluge and Mella are working to a draft protocol for a larger study in cooperation with the Oslo University Hospital (Aker).

When the preliminary protocol is completed, it is time to establish collaborations with other research communities that want to take part in the study.

After that, the research protocol will be submitted to the Committee for Medical and Health Research Ethics and the Norwegian Medicines Agency.

Professor Mella says:

• It is extremely important that the research centers included in the study are dedicated to the task.

• They need people who are very good at diagnostics and that can administer the rituximab treatment in a safe manner for the patients.

• If you can’t accommodate this, it’s probably better for the study to be carried out in fewer institutions.

Adverse Reactions

Rituximab is known to have some serious, but very rare adverse reactions.

• Our experiences in working with cancer patients show that this is a drug that does not trigger a lot of adverse reactions, Mella says.

• What you do, is to deplete the B-cell lymphocytes which are normally responsible for production of antibodies. Because this is done only for a limited period of time, many of the mature B-cells are still circulating in the blood stream.

• The increase in infections in most patients receiving this treatment is small. There is, however, a theoretical risk for serious infections. That is why it is necessary to be alert when looking for emerging signs of infection.

Dr Mella explains that rituximab is a protein substance that is partly produced from human material and partly from mouse material.

• The tendency for allergic reactions is increased compared with some other drugs.

• That is why it is important that the patients receive the drug under observation, preferably at a rheumatological-, neurological- or a cancer ward.

If you are used to administer[ing] rituximab and know what to do if allergic reactions occur, we see this as an easy treatment, Dr. Mella reassures.

• The patients must be under observation for some hours when they receive the treatment in the ward, and they are admitted for 24 hours to make it possible to deal with potential adverse reactions.

• It is important to stress that we do not know if ME patients may have more or other side effects compared to patients with cancer or rheumatological diseases.


Drs. Fluge and Mella have worked for almost three years in their search for biomarkers for ME, thanks to the funding from Western Norway Regional Health Authority.

In their search, biological samples from the study participants are investigated in the laboratory. The patients’ clinical picture is the researchers’ starting point in their search for biomarkers. From there they can reflect where the problem might be located and search for abnormalities.

Dr. Mella admits that there is always a need for money for research; more can be done and things can move forward a little quicker.

Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Mitochondria Ignite™ with NT Factor® Hydroxocobalamin Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Subscribe Now!
Receive up-to-date ME/CFS, Fibromyalgia & Lyme Disease treatment and research news
 Privacy Guaranteed  |  View Archives

Repair Damaged Mitochondria and Reduce Fatigue Up to 45%

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Hydroxocobalamin Extreme™ Hydroxocobalamin Extreme™
The B-12 your brain needs for detox & sharpness
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
MitoQ® MitoQ®
Powerful Antioxidant Support to Mitochondria

Natural Remedies

Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
Stop Bacteria With Nature's Antibiotics Stop Bacteria With Nature's Antibiotics
Coping When Colds or Flu Catch Up with You Coping When Colds or Flu Catch Up with You
Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?
"It's Not Easy Being Green" - But It Is Healthy

What is Fibromyalgia?
Fibromyalgia Diagnosis
Fibromyalgia Symptoms
Fibromyalgia Causes
Fibromyalgia Treatments
Fibromyalgia Diet
Fibromyalgia Medications
M.E. & CFS
What is M.E./CFS?
M.E./CFS Diagnosis
M.E./CFS Symptoms
M.E./CFS Causes
M.E./CFS Treatments
M.E./CFS Diet
M.E./CFS Medications
What is Lyme Disease?
Lyme Disease Diagnosis
Lyme Disease Symptoms
Lyme Disease Causes
Lyme Disease Treatments
Lyme Disease Diet
Lyme Disease Medications
M.E. & CFS
Lyme Disease
General Health
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing